Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 343

Results For "Inc"

6656 News Found

Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr
News | May 22, 2023

Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr

Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023


Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27
Policy | May 22, 2023

Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27

8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector


Modi addresses 76th session of the World Health Assembly in Geneva virtually
News | May 22, 2023

Modi addresses 76th session of the World Health Assembly in Geneva virtually

India’s efforts are aimed at boosting health at the last mile


Croda signs supply deals with Amyris, BSI for vaccine adjuvants
News | May 21, 2023

Croda signs supply deals with Amyris, BSI for vaccine adjuvants

These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.


Abbott India posts Q4FY23 PAT at Rs. 231.42 Cr
News | May 20, 2023

Abbott India posts Q4FY23 PAT at Rs. 231.42 Cr

The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023


Alkem Laboratories posts Q4 FY23 consolidated PAT slides to Rs. 70.98 Cr
News | May 20, 2023

Alkem Laboratories posts Q4 FY23 consolidated PAT slides to Rs. 70.98 Cr

The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023


Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting
Clinical Trials | May 20, 2023

Moderna presents Phase 1/2 of MRNA-3927at 2023 ASGCT Meeting

First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement


KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr
News | May 19, 2023

KIMS posts Q4FY23 consolidated PAT at Rs. 93.27 Cr

The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023


Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
News | May 19, 2023

Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr

Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023


Venus Remedies recognized for R&D excellence by DSIR
News | May 19, 2023

Venus Remedies recognized for R&D excellence by DSIR

Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions